Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 33, 2016 - Issue 2
Submit an article Journal homepage
487
Views
17
CrossRef citations to date
0
Altmetric
CNS tumors

Optic pathway glioma in children: 10 years of experience in a single institution

Dimitrios DoganisDepartment of Oncology, P. & A. Kyriakou Children's Hospital, Athens, GreeceCorrespondence[email protected]
,
Apostolos PourtsidisDepartment of Oncology, P. & A. Kyriakou Children's Hospital, Athens, Greece
,
Kleonikos TsakirisDepartment of Ophthalmology, P. & A. Kyriakou Children's Hospital, Athens, Greece
,
Margarita BakaDepartment of Oncology, P. & A. Kyriakou Children's Hospital, Athens, Greece
,
Agathi KouriDepartment of Ophthalmology, P. & A. Kyriakou Children's Hospital, Athens, Greece
,
Despina BouhoutsouDepartment of Oncology, P. & A. Kyriakou Children's Hospital, Athens, Greece
,
Maria VarvoutsiDepartment of Oncology, P. & A. Kyriakou Children's Hospital, Athens, Greece
,
Marina ServitzoglouDepartment of Oncology, P. & A. Kyriakou Children's Hospital, Athens, Greece
,
Helen DanaDepartment of Oncology, P. & A. Kyriakou Children's Hospital, Athens, Greece
&
Helen KosmidisDepartment of Oncology, P. & A. Kyriakou Children's Hospital, Athens, Greece
 show all
Pages 102-108 | Received 21 Jan 2016, Accepted 13 Feb 2016, Published online: 23 Mar 2016

References

  • Sawamura Y, Kamada K, Kamoshima Y, et al. Role of surgery for optic pathway/hypothalamic astrocytomas in children. Neuro Oncol. 2008;10:725–733.
  • Dutton J. Gliomas of the anterior visual pathway: major review. Surv Ophthalmol. 1994;38:427–452.
  • Mahoney DH, Cohen ME, Friedman HS, et al. Carboplatin is effective therapy for young children with progressive optic pathway tumors: a Pediatric Oncology Group phase II study. Neuro Oncol. 2000;2:213–220.
  • Shuper A1, Horev G, Kornreich L, et al. Visual pathway glioma: an erratic tumour with therapeutic dilemmas. Arch Dis Child. 1997;76:259–263.
  • Listernick R1, Ferner RE, Liu GT, et al. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann Neurol. 2007;61:189–198.
  • Perilongo G. Considerations on the role of chemotherapy and modern radiotherapy in the treatment of childhood low grade glioma. J Neurooncol. 2005;75:301–307.
  • Shamji MF1, Benoit BG. Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications. Neurosurg Focus. 2007;23:E3.
  • Listernick R, Ferner RE, Piersall L, et al. Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology. 2004;63:1944–1946.
  • Moreno L, Bautista F, Ashley S, et al. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence. Eur J Cancer. 2010;46:2253–2259.
  • Dalla Via P, Opocher E, Pinello ML, et al. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neurooncology. 2007;9:430–437.
  • Gutmann DH, Listernick R, Ferner RE. Screening for symptomatic optic pathway glioma in children with neurofibromatosis type 1. Eye (Lond). 2011;25:818.
  • Grill J, Laithier V, Rodriguez D, et al. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr. 2000;159:692–696.
  • Opocher E, Kremer LC, Da Dalt L, et al. Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer. 2006;42:1807–1816.
  • Sievert A, Fisher M. Pediatric low-grade gliomas. J Child Neurol. 2009;24:1397–1408.
  • Fouladi M, Wallace D, Langston JW, et al. Survival and functional outcome of children with hypothalamic/chiasmatic tumors. Cancer. 2003;97:1084–1092.
  • Sutton LN, Molloy PT, Sernyak H, et al. Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. J Neurosurg. 1995;83:583–589.
  • Listernick R, Charrow J, Greenwald MJ, et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994;125:63–66.
  • Balcer LJ, Liu GT, Heller G, et al. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging. Am J Ophthalmol. 2001;131:442–445.
  • Fisher MJ, Loguidice M, Gutmann DH, et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro-Oncology. 2012;14:790–797.
  • Chong AL, Pole JD, Scheinemann K, et al. Optic pathway gliomas in adolescence-time to challenge treatment choices? Neuro Oncol. 2013;15:391–400.
  • Gnekow AK, Kortmann RD, Pietsch T, et al. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy—report from the multicenter treatment study for children and adolescents with a low grade glioma—HIT-LGG 1996—of the Society of Pediatric Oncology and Hematology (GPOH). Klin Padiatr. 2004;216:331–342.
  • Ater JL, Zhou T, Holmes E, et al. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group. J Clin Oncol. 2012;30:2641–2647.
  • Bouffet E, Jakacki R, Goldman S, et al. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol. 2012;30:1358–1363.
  • Gayre GS, Scott IU, Feuer W, et al. Long-term visual outcome in patients with anterior visual pathway gliomas. J Neuroophthalmol. 2001;21:1–7.
  • Tow SL, Chandela S, Miller NR, et al. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol. 2003;28:262–270.
  • Segal L, Darvish-Zargar M, Dilenge ME, et al. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. J AAPOS. 2010;14:155–158.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.